Metraipolis › archive › dc_fa1fa3f3fb8b
Drug Metabolism and Pharmacokinetic Evaluation of a Novel RNase H2 Inhibitor for the Treatment of Triple-Negative Breast Cancer — Europe PMC PMID:40871073
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40871073
- DOI
- 10.3390/pharmaceutics17081052
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T16:45:04.103Z
- SHA-256 of the archived text
3efef0fe7edbaa742b5224dde4253b21cddda7e9d02171a3b199b0953fa830fa- Stable URL of this page
https://metraipolis.com/documento/dc_fa1fa3f3fb8b
How to cite
Drug Metabolism and Pharmacokinetic Evaluation of a Novel RNase H2 Inhibitor for the Treatment of Triple-Negative Breast Cancer — Europe PMC PMID:40871073 — Europe PMC (en), https://europepmc.org/article/MED/40871073 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa1fa3f3fb8b (Metraipolis archive dc_fa1fa3f3fb8b, sha256 3efef0fe7edbaa742b5224dde4253b21cddda7e9d02171a3b199b0953fa830fa)
BibTeX
@misc{dcfa1fa3f3fb8b,
title = {Drug Metabolism and Pharmacokinetic Evaluation of a Novel RNase H2 Inhibitor for the Treatment of Triple-Negative Breast Cancer — Europe PMC PMID:40871073},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40871073},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa1fa3f3fb8b; sha256 3efef0fe7edbaa742b5224dde4253b21cddda7e9d02171a3b199b0953fa830fa},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40871073. Agents can read the archived copy with the MCP tool read_document.